Based on these findings, it could be concluded that HCC-Check and its condensed version outperform AFP by having higher AUCs for HCC detection from non-malignant liver cirrhosis and the ability to correctly identify HCC patients with tumor sizes < 3 cm, CLIP (0–1) and BCLC (A). This evidence concerns the gene AFP and neoplasm.